Sort
17,054 grants matching “genome editing”
Investigating the epigenetics of enhancer function in Cancer
$80,942Ryan Adam Rickels · Duke University · K00 · FY2019 · CA
Epigenomics, RNA, and Gene Regulation (ERGR)
$80,905Kathrin Plath · University Of California Los Angeles · P30 · FY2025 · CA
Gene Targeting & Transgenic Shared Resource
$80,797Eugene Yu · Roswell Park Cancer Institute Corp · P30 · FY2022 · CA
Genetic regulation and immunological function of ERAP2 haplotypes
$80,748Chun Jimmie Ye · University Of California, San Francisco · R01 · FY2021 · AI
Genetic Studies of Sarcomere-based Cardiac Diseases (Diversity Supplement)
$80,632Xiaolei Xu · Mayo Clinic Rochester · R01 · FY2023 · HL
Masters of immunology- how Toxoplasma gondii directly manipulates T cell activation
$80,606Kirk David Christian Jensen · University Of California, Merced · R15 · FY2019 · AI
PROJECT 1
$80,536Reuben S Harris · University Of Texas Hlth Science Center · P01 · FY2023 · CA
Patient-Specific Induced Pluripotent Stem Cells for Modeling Single Ventricle Congenital Heart Disease
$80,429Sharon Lynn Paige · Stanford University · K08 · FY2020 · HL
Genotype-Tissue-Protein: proteomic variation and quantitative trait loci (pQTL)
$80,250Michael P Snyder · Stanford University · U01 · FY2014 · HG
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
$80,224William David Ramos-Lewis · Duke University · F32 · FY2025 · AG
Human stem and progenitor-based models of lung adenocarcinoma
$80,165Preetish Kadur Lakshminarasim · University Of Illinois At Chicago · R03 · FY2025 · CA
Development of a Precision Drug to target Y537S Mutant Estrogen Receptor in Metastatic Breast Cancer
$80,000Murugesan Palaniappan · Baylor College Of Medicine · R03 · FY2022 · CA
Development of a Precision Drug to target Y537S Mutant Estrogen Receptor in Metastatic Breast Cancer
$80,000Murugesan Palaniappan · Baylor College Of Medicine · R03 · FY2023 · CA
DNA damage response and repair of a broken chromosome
$80,000James E Haber · Brandeis University · R35 · FY2018 · GM
Genome Instability induced in cancer cells carrying mutations in Type II topoisomerases
$79,950John L. Nitiss · University Of Illinois At Chicago · R03 · FY2022 · CA
Genome Instability induced in cancer cells carrying mutations in Type II topoisomerases
$79,950John L. Nitiss · University Of Illinois At Chicago · R03 · FY2023 · CA
Investigating the role of the Unfolded Protein Response in Genetic Dilated Cardiomyopathy
$79,756Rachel Baum · Stanford University · F32 · FY2024 · HL
Dissecting gene regulation of stem cell quiescence in Ciona
$79,756Eduardo D. Gigante · Georgia Institute Of Technology · F32 · FY2024 · GM
Gene Editing for DFNA9 Deafness
$79,642Hila Romi · Brigham And Women'S Hospital · F32 · FY2021 · DC
Charcot-Marie-Tooth (CMT) Disease
$79,542James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Genetic Determinants of Epilepsy in Murine Systems
$79,404Wayne N. Frankel · Columbia University Health Sciences · R37 · FY2018 · NS
In vivo analysis of gastrointestinal epithelium morphogenesis
$79,250Stephanie Woo · University Of California, San Francisco · R03 · FY2015 · DK
Unraveling the essential gene regulatory network underlying notochord development in Ciona
$79,250Anna Di Gregorio · New York University · R03 · FY2019 · HD
Unraveling the essential gene regulatory network underlying notochord development in Ciona
$79,250Anna Di Gregorio · New York University · R03 · FY2020 · HD
A pilot study to define maintained alterations in mitochondrial DNA of eosinophilic esophagitis patients that may be exploited clinically
$79,250Kelly A Whelan · Temple Univ Of The Commonwealth · R03 · FY2022 · AI